Metastatic Breast Cancer
Recently Published Documents
(FIVE YEARS 6495)
(FIVE YEARS 60)
Assessing financial toxicity in patients with metastatic breast cancer: A single institution experience during the COVID-19 pandemic.
Strategic integration of genetic testing and counseling in patients with breast cancer in an oncology care model (OCM) multisite community-based practice.
Evaluating specialty referral, research involvement, and PROs in a CNS-involved metastatic breast cancer care coordination program.
Treatment delays in older women with nonmetastatic breast cancer treated at minority-serving hospitals.
Patient-reported outcomes to assess symptoms in patients with metastatic breast cancer: Pilot implementation project.
FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer
Fdg Pet ◽
Pet Ct ◽
Low Risk ◽
Gene Set ◽
Ribociclib in the treatment of HR+ HER2-negative metastatic breast cancer: updated results from the randomized clinical trials and their role in the clinical practice
Clinical Features and Serological Markers Risk Model Predicts Overall Survival in Patients Undergoing Breast Cancer and Bone Metastasis Surgeries